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Abstract 
Introduction: The aim of the study is to analyze the relationship between normative and non-normative 
thyroid tests (TSH, TT4, TT3, FT3, FT4, anti-TPO, anti-Tg, AB-TSHR) and the level of cognitive functions in post-
menopausal women. 
Material and methods: The study group consisted of 383 women from south-eastern Poland, aged 50-65 
years. The cognitive functions were evaluated using a diagnostic instrument – Central Nervous System – Vital 
Signs (CNS-VS). Blood was collected for determination of the following parameters: TSH, TT4, TT3, FT3, FT4, 
anti-TPO, anti-Tg, AB-TSHR. 
Results: There were significant differences in NCI, executive functions, psychomotor speed, reaction time, 
complex attention and cognitive flexibility, depending on the normative and non-normative level of TSH. Wom-
en whose level of FT3 was at the lower limit of the normal range obtained poorer results in psychomotor 
speed, while subjects with levels of FT4 below the standard achieved significantly lower scores for this function. 
The relationship between NCI and cognitive functions, and the normative and non-normative anti-TPO results, 
showed significant differences in verbal memory, visual memory, processing speed and reaction time. The level 
of AB-TSHR reported as normal or above the norm significantly differentiated from the results of NCI, processing 
speed, executive functions, psychomotor speed, complex attention and cognitive flexibility. 
Conclusions: Concentrations of laboratory parameters assessing the thyroid function located within the 
upper limits of the normal range showed a different relationship with the cognitive performance than concen-
trations located within the lower limits of the standard.
Key words: thyroid testing, cognitive dysfunction, menopausal age.
Introduction 
Both hyperthyroidism and hypothyroidism can 
cause cognitive dysfunction by affecting the functions 
of the central nervous system. The issues of cognitive 
impairment in thyroid disorders are significantly less 
well-understood and are currently the subject of many 
studies. Complex attention, response speed, data pro-
cessing and memory disorders were observed in the 
case of thyroid hormone dysfunction [1, 2]. 
Depression is one of the most frequently reported 
mental disorders associated with dysfunction of the 
thyroid gland. A fully developed form of the disease or 
a subclinical form is more common in patients with hy-
pothyroidism, but may also appear in patients with hy-
perthyroidism [3]. A full-blown depressive syndrome can 
be observed in 50% of patients with hypothyroidism. 
Bipolar disorders are also reported in the course 
of thyroid function disorders. Complaints of abnormal 
psychological well-being in patients with hypothyroid-
ism may precede other symptoms. Anxiety is a mental 
disorder associated with hypothyroidism, which occurs 
in approximately 30% of patients with this disease. 
The incidence of cognitive impairment in hyperthy-
roidism is lower than in hypothyroidism [4]. Neuropsy-
chological testing performed in patients with hyper-
thyroidism indicated attention disorders, especially 
problems with concentration, fresh memory and execu-
tive functions [3, 5, 6]. 
Cognitive impairment in patients with thyroid dys-
function is probably related to the malfunction of the 
neurotransmitter systems in the brain: dopaminergic, 
noradrenergic and serotonergic [7]. The relationship is 
emphasized between the impaired secretion of thyroid 
hormones, disturbed function of the neurotransmitter 
systems, depression and cognitive impairment [1]. 
Study objective
The analysis of the relationship between the nor-
mative (low, medium and high standard) and non-nor-
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mative thyroid tests (TSH, TT4, TT3, FT3, FT4, anti-TPO, 
anti-Tg, AB-TSHR), and the level of cognitive functions 
in postmenopausal women.
Material and methods
Material
The study was conducted in 2011 and 2012 at the 
Institute of Rural Health in Lublin. The study group com-
prised women from south-eastern Poland. The criteria 
of inclusion in the study were as follows: age 50-65, 
good general health, at least elementary education level. 
The women were also qualified into the study group 
based on clinical symptoms – minimum 2 years from the 
last menstrual period. The criteria for exclusion from the 
study were as follows: active cancerous disease within 
a  period of five years before recruitment; mental dis-
eases in medical history, including depression before 
menopause; addiction to drugs or alcohol; diagnosed 
nosologic unit with symptoms of dementia. At the stage 
of qualification for the study a brief Montreal Cognitive 
Assessment scale was conducted in order to include pa-
tients who did not show features of dementia [8]. The 
Montreal Cognitive Assessment scale for the evaluation 
of cognitive functions was designed as a quick screening 
instrument for the evaluation of mild cognitive dysfunc-
tions, with a Polish adaptation of the scale by Magierska 
et al. The maximum score in this test is 30; and results of 
26 or more are considered normal. All the women includ-
ed in the study obtained more than 26 in the MoCA test.
Neuropsychological assessment
Cognitive functions were evaluated using the dia-
gnostic instrument – Central Nervous System – Vital 
Signs (CNS-VS) (Polish version) [9] with software by 
CNS Vital Signs (1829 East Franklin St., Bldg. 500, 
Chapel Hill, NC 27514, USA). The instrument, in the 
form of a  battery of computer tests, is standardized, 
has been subjected to the full validation procedure, and 
has a Polish adaptation. The entire research procedure 
with the use of a  computer was performed in Polish. 
The report concerning test results is published in Eng-
lish. CNS-VS covers the following tests: Verbal Memory 
Test – VBM, a test examining motor function – Finger 
Tapping Test – FTT, the Symbol Digit Modalities Test – 
SDMT, the Stroop Test – ST, the Shifting Attention Test – 
SAT, and the Continuous Performance. CNS-VS assesses 
nine cognitive functions: memory, verbal memory, visu-
al memory, processing speed, executive functions, psy-
chomotor speed, reaction time, complex attention, and 
cognitive flexibility. Based on five of these functions: 
memory, psychomotor speed, reaction time, complex 
attention, and cognitive flexibility, the Neurocognitive 
Index (NCI) is calculated. The computer data from the 
CNS-VS test provide: raw results, standardized results, 
percentiles, and evaluations according to the 5-point 
scale for each of the nine cognitive functions examined 
and the Neurocognitive Index. These evaluations are as 
follows: above average (more than 109 standardized 
points), average (90-109), below average (80-89), low 
(70-79), or very low (less than 70).
Laboratory tests 
Blood was collected for determination of the follow-
ing parameters: TSH, TT4, TT3, FT3, FT4, anti-TPO, anti-
Tg, AB-TSHR. The samples were immediately sent to 
the laboratory. The determinations were performed in 
the accredited laboratory SYNEVO. 
Standards of the considered tests for postmenopau-
sal women: TSH: 0.27-4.4 mU/l; TT4: 66-181 nmol/l; TT3: 
1.3-3.1 nmol/l; FT4: 12-22 pmol/l; FT3: 3.1-6.8 pmol/l; 
Anti-TPO: 0-34 IU/l; Anti-Tg: 0-115 IU/l; AB-TSHR: 
0-15 IU/l (SYNEVO 2011). 
The thyroid tests were analyzed at the intervals of 
laboratory standards (below the norm, normal, above 
the norm). Due to a large number of women with normal 
characteristics of the thyroid gland, the normal range 
was divided into three sub-intervals of equal span; for 
the purposes of this study they were called as follows: 
low standard, middle standard and high standard. 
Statistical analysis
The tables show the absolute (n) and relative (the 
ratio of the number of units of a given variant of char-
acteristics to the sample size, expressed in %) numbers, 
minimum and maximum values, arithmetic mean (M) 
reflecting the average level, and standard deviation 
(SD) measuring the degree of dispersion of measure-
ments around the arithmetic mean, results of the re-
gression analysis, as well as empirical values of statisti-
cal tests and the critical significance level p. It is the 
lowest – given the data results of a test – significance 
level at which the null hypothesis can be rejected. 
Mean and standard deviation were calculated for 
NCI and 9 cognitive functions (in points) according to 
the characteristics of the thyroid in the laboratory test 
standards; the comparison used the t test of the differ-
ence between paired values (for two compartments of 
laboratory ranges) and analysis of the variance F test 
(for more than two laboratory ranges). 
If the null hypothesis was rejected, no significant dif-
ference between the cognitive function results and lab-
oratory standard compartments was indicated by mul-
tiple comparison tests (the least significant difference). 
The graphs illustrate only the significant relation-
ships between NCI, the 9 cognitive functions, and the 
characteristics of the thyroid gland. 
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The sample size was 383. Due to the large sample 
size, the critical normal distributions of estimates were 
accepted for the parameters. 
The statistical tests were accepted at a level of sig-
nificance of 0.05. 
Results 
Nine cognitive functions and the neurocognitive in-
dex were evaluated using the CNS-VS test in the tested 
women. The women obtained the result of the Neuro-
cognitive Index at a level of 84.4 points on average. This 
proved a below average overall assessment of the cog-
nitive functions. The worst results were achieved in the 
tests for cognitive flexibility (78.64 points on average), 
processing speed (79.25 points on average), and execu-
tive functions (79.75 points on average). This indicates 
a poor assessment of cognitive functions. The patients 
scored slightly better in the tests for complex attention 
(82.24 points on average), psychomotor speed (83.42 
points on average), and, even better, reaction time 
(86.87 points on average). This indicates below aver-
age evaluations of these cognitive functions. The tested 
women scored highest in the tests for memory (90.15 
points on average), including verbal memory (91.22 
points on average) and visual memory (93.37 points on 
average). 
The results of NCI and cognitive functions (in 
points) were analyzed in the tested women, depending 
on the level of TSH, in three intervals of the standard 
(low, middle and high) and above the norm. Significant 
differences were observed in NCI, executive functions, 
psychomotor speed, reaction time, complex attention 
and cognitive flexibility, depending on the normative 
and non-normative TSH level (Table I, Fig. 1). 
Women with the low TSH standard compared to 
women with the high standard had better results in 
NCI (86.75 points on average – assessment below the 
average vs. 77.67 points – poor score), executive func-
tions (83.63 points on average – assessment below the 
average vs. 67.69 points – very poor assessment), psy-
chomotor speed (85.68 points on average – assessment 
below the average vs. 79.57 points – poor assessment), 
complex attention (86.20 points – assessment below 
the average vs. 67.43 points – very poor assessment) 
and cognitive flexibility (82.40 points on average – as-
sessment below the average vs. 66.26 points – very poor 
assessment). Subjects with the high TSH standard had 
a  lower performance of these functions than women 
with TSH above the norm, who were found to be below 
the average evaluation of NCI (84.61 points on average), 
Tab. I. Cognitive functions (standardized scores) according to the TSH norms
Domain Low standard Middle standard High standard Above standard Significance of differences
M SD M SD M SD M SD F p
NCI 86.75 15.19 82.40 14.98 77.67 18.32 84.61 19.23 5.188 0.002
Memory 90.90 14.89 90.33 17.30 86.61 16.42 90.52 15.09 1.100 0.349
Verbal memory 91.58 18.28 90.26 17.76 90.26 17.52 92.77 14.53 0.238 0.870
Visual memory 94.36 13.53 93.65 18.02 89.19 16.02 92.84 14.64 1.748 0.157
Processing speed 79.69 13.90 78.19 16.09 78.00 14.41 81.00 13.13 0.497 0.685
Executive functions 83.63 24.12 77.74 22.93 67.69 27.18 78.35 26.87 6.377 0.000
Psychomotor speed 85.68 15.63 79.33 20.40 79.57 20.33 84.42 21.66 3.382 0.018
Reaction time 88.71 16.15 82.76 16.97 86.87 17.37 84.19 17.56 2.762 0.042
Complex attention 86.20 26.50 81.69 25.83 67.43 33.13 81.26 33.95 6.513 0.000
Cognitive flexibility 82.40 25.29 76.88 23.96 66.26 28.07 77.90 27.21 5.931 0.001
NCI – Neurocognitive Index
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Fig. 1. Cognitive functions according to the TSH standards
Co
gn
it
iv
e 
fu
nc
ti
on
s
Przegląd Menopauzalny/Menopause Review 13(4) 2014
236
psychomotor speed (84.42 points on average), complex 
attention (81.26 points on average), as well as poor as-
sessment of executive functions (78.35 points on aver-
age) and cognitive flexibility (77.90 points on average).
Subjects with a level of TSH within the lower limit 
of the normal range had better reaction time (88.71 
points on average, or evaluation below the average) 
than subjects with TSH in the middle standard (82.76 
points on average) and above the norm (84.19 points 
on average). Also, subjects with the TSH level in the 
middle standard obtained lower results of these func-
tions than those with TSH in the high range of the norm 
(86.87 points on average).
The analysis of the results of NCI and cognitive func-
tions (in points) in the tested women depending on the 
level of FT3, located in the low, middle or high stand-
ards, revealed significant differences in psychomotor 
speed. The women who had low-normal FT3 obtained 
poorer results in psychomotor speed compared to the 
subjects with the middle and high standards (82.41 vs. 
86.85 points on average) (Table II).
The analysis of the results of NCI and cognitive 
functions (in points) of the tested women depending 
on the level of FT4 below the standards and in the 
three standard intervals, showed significant differenc-
es in psychomotor speed. The subjects with the level 
of FT4 below standard achieved significantly lower 
scores in this function (76.60 points on average, or 
poor assessment) compared to the women with the 
middle (87.42 points on average) and low FT4 stand-
Tab. II. Cognitive functions (standardized scores) according to the FT3 standards
Domain Low standard Middle or high standard Significance of differences
M SD M SD t p
NCI 84.53 14.92 85.59 18.10 0.597 0.551
Memory 90.67 15.48 89.20 16.21 0.847 0.398
Verbal memory 90.93 17.84 92.00 17.88 0.543 0.588
Visual memory 94.43 15.25 91.23 14.59 1.935 0.054
Processing speed 79.24 14.23 79.45 14.86 0.132 0.895
Executive functions 79.50 24.51 82.02 24.93 0.929 0.354
Psychomotor speed 82.41 18.78 86.85 15.64 2.259 0.024
Reaction time 86.43 16.49 88.29 17.07 1.011 0.313
Complex attention 82.33 27.30 84.14 29.48 0.584 0.559
Cognitive flexibility 78.49 25.43 80.51 26.71 0.711 0.478
NCI – Neurocognitive Index
Tab. III. Cognitive functions (standardized scores) according to the FT4 standards
Domain Below standard Low standard Middle standard High standard Significance of differences
M SD M SD M SD M SD F p
NCI 84.30 11.94 82.97 18.39 86.29 14.35 86.89 14.43 1.250 0.291
Memory 88.16 14.62 90.10 16.46 91.34 15.16 88.42 13.17 0.571 0.634
Verbal memory 88.14 14.81 90.78 18.11 93.75 18.13 85.89 15.68 1.993 0.115
Visual memory 92.93 17.89 93.94 14.61 92.47 15.13 96.58 11.53 0.547 0.651
Processing speed 80.86 11.74 77.41 14.27 80.81 14.29 82.63 19.41 2.078 0.103
Executive functions 82.79 21.20 78.27 26.86 80.65 23.29 82.95 28.82 0.578 0.630
Psychomotor speed 76.60 19.89 82.14 19.48 87.42 14.77 83.05 16.97 4.734 0.003
Reaction time 85.21 13.27 85.37 17.38 89.63 16.27 88.58 15.61 1.993 0.115
Complex attention 87.65 23.66 79.02 31.83 84.58 24.83 85.79 31.75 1.678 0.171
Cognitive flexibility 81.79 22.72 76.82 28.21 79.91 23.61 81.89 29.92 0.704 0.550
NCI – Neurocognitive Index
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ards (82.14 points on average), who scored below the 
average (Table III).
Furthermore, it was checked whether there were 
significant differences between the results of NCI and 
cognitive functions (in points), and the levels of TT3 
and TT4 in the low, middle and high standards. There 
were significant differences in memory and psychomo-
tor speed depending on the TT3 in the low, middle and 
high standards (Table IV). 
Women with the TT3 level located in the low stand-
ard had better results in these functions (the average 
memory scores were at the level of 91.48 points, and 
psychomotor speed at 84.91 points) compared to the 
women in the middle or high TT3 standards (the av-
erage memory scores amounted to 88.03 points, and 
psychomotor speed to 80.74 points). In contrast, no sig-
nificant differences were found in NCI and the cognitive 
functions depending on TT4 in the two compartments’ 
standards (Table V). 
The analysis of the relationship between NCI, cogni-
tive functions (in points) and the normative and non-
normative anti-TPO results revealed significant differ-
ences in verbal memory, visual memory, processing 
speed and reaction time (Table VI).
The subjects with anti-TPO levels in the middle 
standard achieved better verbal memory performance 
(94.57 points on average, or the average assessment) 
compared to the women with anti-TPO in the low norm 
(the average scores of verbal memory amounted to 88.83 
points) and those above the standard (88.96 points on 
average). These two groups of women received results 
below the average in the evaluation of this function.
Tab. IV. Cognitive functions (standardized scores) according to the TT3 standards 
Domain Low standard Middle or high standard Significance of differences
M SD M SD t p
NCI 85.14 15.40 83.09 17.34 1.202 0.230
Memory 91.48 14.66 88.03 16.95 2.099 0.036
Verbal memory 92.47 17.39 89.52 18.30 1.588 0.113
Visual memory 93.94 14.79 92.09 15.53 1.166 0.244
Processing speed 80.21 15.41 78.20 13.00 1.326 0.186
Executive functions 79.83 24.49 79.34 25.97 0.187 0.852
Psychomotor speed 84.91 17.20 80.74 19.07 2.211 0.028
Reaction time 86.93 16.11 86.31 17.87 0.354 0.723
Complex attention 83.53 26.85 80.59 31.15 0.975 0.330
Cognitive flexibility 79.08 25.13 77.81 27.46 0.467 0.641
NCI – Neurocognitive Index
Tab. V. Cognitive functions (standardized scores) according to the TT4 standards
Domain Low standard Middle or high standard Significance of differences
M SD M SD t p
NCI 84.71 16.03 83.56 16.91 0.649 0.517
Memory 90.59 15.97 89.15 15.27 0.847 0.398
Verbal memory 91.19 17.62 90.98 18.28 0.107 0.915
Visual memory 94.00 15.89 92.23 13.28 1.092 0.276
Processing speed 78.67 14.90 80.27 13.46 1.029 0.304
Executive functions 80.52 24.92 77.63 25.68 1.064 0.288
Psychomotor speed 83.68 17.69 83.17 18.85 0.263 0.793
Reaction time 86.73 15.33 86.99 19.31 0.143 0.886
Complex attention 81.80 29.35 82.40 27.86 0.192 0.848
Cognitive flexibility 79.46 25.86 76.42 26.85 1.074 0.284
NCI – Neurocognitive Index
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As for visual memory, women with anti-TPO in the 
low norm (96.36 points on average) obtained better 
results compared to subjects in the middle anti-TPO 
standard (92.65 points on average) and above the norm 
(90.46 points on average).
In terms of processing speed, women with anti-
TPO in the middle standard (82.06 points on average, 
or assessment below the average) achieved signifi-
cantly better results compared to women in the low 
norm (77.19 points on average) and above the standard 
(76.96 points). These two groups of women had poor 
evaluation in the function.
The results of reaction time were significantly low-
er in subjects with levels of anti-TPO in the low norm 
(83.71 points on average) compared to the sample in 
the middle (88.25 points on average) and high stand-
ards (91.60 points on average).
The normal level of AB-TSHR or above the standard 
significantly differentiated the results of NCI, process-
ing speed, executive functions, psychomotor speed, 
complex attention and cognitive flexibility (Table VII).
Subjects with the AB-TSHR levels in the low or mid-
dle standards had significantly better results of NCI, ex-
ecutive functions, psychomotor speed, complex atten-
tion and cognitive flexibility (the average values were: 
86.59; 84.76; 85.81; 87.91; 83.52 points, respectively, or 
assessment below the average) compared with women 
whose levels of AB-TSHR were above the norm (the av-
erage values were: 81.92; 75.20; 80.50; 77.14; 73.86 
points, respectively, or mostly poor evaluation), and 
these women, in turn, had significantly lower scores in 
NCI and the listed features than women with the high 
AB-TSHR standard (the average values: 85.69; 81.45; 
84.94; 84.09; 80.66 points, respectively). 
Another relationship was found in the results of 
processing speed. The subjects with AB-TSHR above the 
norm had better results (the average value was 82.27 
points, i.e. the assessment was below the average) than 
those with AB-TSHR located in the low or middle stand-
ards (77.01 points on average) and the high standard 
(77.43 points on average). These two groups of women 
received poor evaluation in the function. 
Discussion 
Other researchers have shown that deviation from 
thyroid hormone levels may be a risk factor for Alzhei-
mer’s disease [10]. It was found that low levels, but 
within the normal range, of thyroxine were associated 
with a higher risk of cognitive impairment during the 
three years of observation in older women [11]. 
Authors have also dealt with the relationship be-
tween subclinical thyroid disease, variations in the thy-
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Fig. 2. Cognitive functions according to the Anti-TPO standards
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Tab. VI. Cognitive functions (standardized scores) according to the Anti-TPO standards 
Domain Low standard Middle standard High standard Above standard Significance of differences
M SD M SD M SD M SD F p
NCI 84.18 15.80 85.86 16.67 82.50 14.89 83.27 16.68 0.653 0.582
Memory 90.42 15.31 91.72 14.70 91.63 13.96 87.09 17.58 1.763 0.154
Verbal memory 88.83 18.79 94.57 14.73 93.50 18.54 88.96 19.31 3.065 0.028
Visual memory 96.36 11.72 92.65 16.02 93.07 14.85 90.46 16.99 2.986 0.031
Processing speed 77.19 15.91 82.06 12.43 82.63 9.27 76.96 15.29 4.011 0.008
Executive functions 80.37 24.63 81.60 26.11 73.67 25.83 78.26 23.93 0.967 0.408
Psychomotor speed 84.16 16.96 83.56 18.48 82.53 18.74 82.53 18.95 0.171 0.916
Reaction time 83.71 16.92 88.25 15.83 91.60 18.75 87.66 16.56 2.710 0.045
Complex attention 84.21 26.01 84.19 29.96 78.03 26.24 78.18 30.63 1.251 0.291
Cognitive flexibility 79.11 25.57 80.27 27.87 73.50 24.38 77.34 24.76 0.651 0.582
NCI – Neurocognitive Index
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roid function within the normal range, and impaired 
cognitive function in healthy adults and patients with 
dementia. Several studies, including those conducted 
in the elderly, reported that subclinical hypothyroidism 
(normal FT4 with elevated TSH) was associated with an 
impaired cognitive function in elderly patients [12-14]. 
Other studies suggest that differences in total thyrox-
ine within the normal range are positively related to 
the general cognitive function in healthy elderly people 
[15], while elevated FT4 levels may worsen the cogni-
tive deficits and cause depression in patients with Alz-
heimer’s disease [16]. 
The studies also revealed that postmenopausal 
women had significant differences in NCI, executive 
functions, psychomotor speed, reaction time, complex 
attention and cognitive flexibility, depending on nor-
mative (in three intervals of the norm) and non-nor-
mative TSH levels. The women in the low TSH standard 
had better results in NCI, executive functions, psycho-
motor speed, complex attention and cognitive flex-
ibility compared to the women in the high standard. 
The subjects with TSH in the lower limit of the norm 
had better response time than those with TSH in the 
middle of the norm and above. Also, subjects with TSH 
in the middle range of the standard had lower results 
in this function than subjects with TSH in the high 
range of the norm. 
Women with low-normal FT3 obtained poorer re-
sults in psychomotor speed compared to subjects with 
the middle or high standards. Subjects with levels of 
FT4 below the standard achieved significantly lower 
scores in this function compared to women with FT4 
within the middle and low standards. 
Women with TT3 levels within the low norm had 
better memory and psychomotor speed compared to 
women with the middle or high TT3 standards. 
The authors of other studies, which were aimed to 
assess the presence of possible significant differences 
in cognition in elderly patients affected by subclinical 
hypothyroidism, have noted that patients with this 
thyroid disorder had considerably lower MMSE scores 
compared with euthyroid individuals [17]. Another re-
port showed a group of 425 patients aged from 65 to 
85 years with a weakening of verbal memory in sub-
clinical hypothyroidism [18]. 
Similar results with respect to TSH were obtained by 
Hogervorst et al. in a study on a group of 1,047 people 
aged 64 years. During two years of observation, the au-
thors found that high levels of TSH positively correlated 
with poorer results of MMSE, regardless of the level of 
FT4, gender, education or mood. Other results of stud-
ies on FT4 noted that high normal FT4 positively cor-
related with worse outcomes in MMSE, and a reduction 
Tab. VII. Cognitive functions (standardized scores) according to the AB-TSHR standards
Domain Low or middle standard High standard Above standard Significance of differences
M SD M SD M SD F p
NCI 86.59 16.99 85.69 15.48 81.92 16.24 3.074 0.047
Memory 90.91 14.55 90.89 15.77 89.01 16.19 0.671 0.512
Verbal memory 90.14 19.24 92.69 17.69 90.52 16.87 0.763 0.467
Visual memory 95.53 12.86 92.78 15.41 92.61 15.84 1.241 0.290
Processing speed 77.01 17.45 77.43 12.85 82.27 13.13 5.737 0.004
Executive functions 84.76 23.38 81.45 24.66 75.20 25.82 4.732 0.009
Psychomotor speed 85.81 16.53 84.94 15.78 80.59 20.51 3.192 0.042
Reaction time 86.79 14.41 87.37 16.53 86.46 18.21 0.109 0.897
Complex attention 87.91 24.99 84.09 27.96 77.14 30.57 4.571 0.011
Cognitive flexibility 83.52 25.33 80.66 25.26 73.86 26.64 4.658 0.010
NCI – Neurocognitive Index
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Fig. 3. Cognitive functions according to the AB-TSHR standards
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by at least 4 points in the test result within two years of 
observation. The authors suggest the need for thyroid 
function tests in older people with handicapped cogni-
tive functions. They cannot, however, explain why high 
normal FT4 values positively correlated with acceler-
ated cognitive decline [19]. 
Other authors present the results of a meta-analysis 
based on 23 studies. The evaluation included the rela-
tionship between subclinical hyperthyroidism or low 
levels of TSH and cognitive functions. Based on fourteen 
properly designed studies they displayed the relation-
ship between subclinical hyperthyroidism and cogni-
tive impairment or dementia. According to the authors, 
there is a large amount of evidence on the relationship 
between subclinical hyperthyroidism and cognitive im-
pairment, but there is no proof that anti-thyroid treat-
ment may alleviate the symptoms of dementia [20]. 
However, one of the latest reports on a study con-
ducted in a group of 5154 men and women aged 70-82 
years without previously diagnosed thyroid dysfunction, 
examined cognitive functions using five neuropsycho-
logical tests, at baseline and at four consecutive time 
points during a follow-up of 3 years. It showed no dif-
ferences between the results of cognitive tests in sub-
clinical hyperthyroidism and hypothyroidism compared 
to the outcomes obtained by euthyroid individuals [21]. 
Subjects with levels of anti-TPO in the middle stand-
ard achieved better results in verbal memory and pro-
cessing speed compared to women with the anti-TPO 
concentration in the low standard and those above the 
norm. As for visual memory and reaction time, women 
with the low anti-TPO standard obtained better results 
compared to the subjects in the middle anti-TPO norm 
and above the standard. 
Subjects with levels of AB-TSHR in the low or middle 
norms had significantly better results in NCI, executive 
functions, psychomotor speed, complex attention and 
cognitive flexibility compared to women with AB-TSHR 
levels above the norm. In turn, they obtained consider-
ably lower scores in NCI and the listed features than the 
women with the high AB-TSHR standard. Another rela-
tionship was found in the results of processing speed. 
In contrast, subjects with AB-TSHR levels above stand-
ard were better in processing speed than subjects with 
the AB-TSHR value located in the low, middle or high 
standards. 
Like the previously-quoted study conducted by Gri-
gorova et al., our work evaluated the effect of the auto-
antibodies level on cognitive functions. It was found 
that the higher concentrations of anti-thyroglobulin 
antibodies positively correlated with more errors in the 
Trail Making Test Part B, Word Fluency test, and Design 
Fluency test. The authors suggest that higher levels of 
FT3 and TgAb, but within the normal range, may ad-
versely affect executive functions, but this was not ob-
served in our study [22]. 
In order to confirm the relationship between thyroid 
dysfunction and the results of cognitive tests, changes 
in these functions after the treatment are also worth 
mentioning. In particular, the treatment of hypothyroid-
ism, including the subclinical form, can bring benefits 
in terms of cognition, which was confirmed in the lit-
erature. 
The studies have shown that patients with hypothy-
roidism and memory disorders achieved an improve-
ment in this area after treatment with L-thyroxine [23, 
24]. A possibility to reverse some aspects of cognitive 
disorders was demonstrated, especially in hypothyroid-
ism, after the use of L-thyroxine. Bono et al. [25] re-
ported a  small but significant improvement in verbal 
fluidity in women with subclinical hypothyroidism after 
6 months of treatment, but the study failed to prove 
a  correlation between the changes in TSH and treat-
ment. The study conducted by del Ser Quijano et al. 
showed that treatment with L-thyroxine significantly 
improved multiple cognitive functions, including com-
plex attention, memory, verbal fluidity and executive 
functions, in comparison with the control group [26]. 
A recent, randomized, placebo-controlled study evaluat-
ing the effects of L-thyroxine on the cognitive function, 
however, did not confirm the hopes of preventing unfa-
vorable changes in cognition through the treatment of 
thyroid dysfunction at the sub-clinical level. The ana-
lysis of data from the MMSE test, Middlesex Elderly 
Assessment of Mental State test, and Trail-Making test 
revealed that there was no conclusive evidence that 
the treatment of elderly patients with subclinical hypo-
thyroidism using L-thyroxine improved their cognitive 
functions [27]. 
Conclusions 
The concentrations of the tested laboratory param-
eters of the thyroid functional status located within the 
upper limits of the normal range showed a  different 
relationship with cognitive performance than the con-
centrations within the lower limits of the normal range. 
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